Richard Law CFA

Stock Analyst at Goldman Sachs

(1.93)
# 3,409
Out of 5,136 analysts
140
Total ratings
40.3%
Success rate
0.5%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Richard Law CFA

Olema Pharmaceuticals
Nov 11, 2026
Reiterated: Buy
Price Target: $18 → $13
Current: $7.27
Upside: +78.82%
Celldex Therapeutics
Nov 6, 2026
Reiterated: Hold
Price Target: $28 → $29
Current: $30.65
Upside: -5.38%
Viridian Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $40 → $53
Current: $30.86
Upside: +71.74%
Bicara Therapeutics
Oct 29, 2026
Downgraded: Sell
Price Target: $20 → $8
Current: $10.18
Upside: -21.41%
Viking Therapeutics
Oct 28, 2026
Rated: Hold
Price Target: $38 → $34
Current: $28.66
Upside: +18.63%
Arcus Biosciences
Oct 19, 2026
Reiterated: Buy
Price Target: $42
Current: $18.67
Upside: +124.96%
Rocket Pharmaceuticals
Oct 8, 2026
Upgraded: Hold
Price Target: $3 → $4
Current: $2.45
Upside: +63.27%
Protagonist Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $186
Current: $136.26
Upside: +36.50%
Mineralys Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $42 → $40
Current: $15.52
Upside: +157.73%
Silence Therapeutics
Jul 27, 2026
Reiterated: Sell
Price Target: $4
Current: $19.79
Upside: -79.79%
Reiterated: Buy
Price Target: $36 → $46
Current: $38.77
Upside: +18.65%
Reiterated: Sell
Price Target: $11 → $12
Current: $12.56
Upside: -4.46%
Reiterated: Hold
Price Target: $29 → $33
Current: $27.39
Upside: +20.50%
Reiterated: Hold
Price Target: $36 → $31
Current: $9.33
Upside: n/a
Reiterated: Hold
Price Target: $47
Current: $25.15
Upside: n/a
Reiterated: Hold
Price Target: $62 → $63
Current: $45.15
Upside: n/a
Reiterated: Hold
Price Target: $36 → $37
Current: $136.64
Upside: n/a
Reiterated: Buy
Price Target: $76
Current: $11.17
Upside: n/a
Reiterated: Hold
Price Target: $11
Current: $10.50
Upside: n/a
Reiterated: Buy
Price Target: $61
Current: $6.92
Upside: n/a
Reiterated: Hold
Price Target: $15 → $14
Current: $2.51
Upside: n/a
Upgraded: Hold
Price Target: $10
Current: $3.00
Upside: n/a